Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
GRI Bio Logo
GRI Bio Growth Score
84
CB Rank
23100
Heat Score
59
GRI Bio is a biotech company that develops therapies to treat inflammatory diseases.
Founded
obfuscation
PublicPost-IPO Equity La Jolla, California, United States1-10 www.gribio.com/
Biopharma
Biotechnology
Life Science
Pharmaceutical
Overview

GRI Bio
Total Funding
obfuscation
Growth Score
84
Heat Score
59

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score84
-12 pts
in past quarter
Heat Score 59
10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About GRI Bio

CB Rank
23100
GRI Bio is a biotech company that develops therapies to treat inflammatory diseases.
Founded
obfuscation
PublicPost-IPO Equity La Jolla, California, United States1-10 www.gribio.com/
Biopharma
Biotechnology
Life Science
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name GRI Bio Inc.
Also Known As Glycoregimmune, GRI
Operating Status Active
Stock Symbol  NASDAQ:GRI
Company Type For Profit
Founders  Marc Hertz
About the Company
GRI Bio is a biotechnology company that develops therapies to treat inflammatory diseases. Its cell-based therapies are developed to treat liver disease and autoimmunity deficiencies by targeting the regulation of NKT cells.
Phone Number (619) 400-1171
Predictions & Insights

Growth Insight

See this Growth Insight
GRI Bio is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

GRI-0621
An oral small molecule inhibitor targeting type 1 invariant Natural Killer T (iNKT) cells to treat idiopathic pulmonary fibrosis (IPF) by modulating early inflammatory pathways.
Type 2 NKT Agonists Pipeline
A pipeline of novel type 2 Natural Killer T (NKT) cell agonists under development for treating systemic lupus erythematosus and other autoimmune diseases.

Research & Development

GRI Bio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - GRI Bio Logo
Post-IPO Equity - GRI Bio
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Science Foundation Logo
National Science Foundation
Yes
Grant - GRI Bio Logo
Grant - GRI Bio
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - GRI Bio Logo
Grant - GRI Bio
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - GRI Bio Logo
Grant - GRI Bio
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - GRI Bio Logo
Grant - GRI Bio
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - GRI Bio Logo
Grant - GRI Bio
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 2

Employee Profiles

News

News and Press

News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 17, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

289
-43.55%
 in past month

IT Spend

$65.3KThis year, GRI Bio is projected to spend $65.3K on IT, according to Aberdeen.

Actively Used Products

10GRI Bio uses 10 technology products and services including HTML5, Google Maps API, and  Apache Server, according to G2 Stack.
Sub-Organizations
Frequently Asked Questions

Where is GRI Bio's headquarters? GRI Bio is located in La Jolla, California, United States.Who invested in GRI Bio? GRI Bio is funded by National Science Foundation.When was the last funding round for GRI Bio? GRI Bio closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are GRI Bio's competitors? Alternatives and possible competitors to GRI Bio may include Abivax, Jade Biosciences, and  BioAge Labs.How much funding has GRI Bio raised to date? GRI Bio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|